Latest filing published 17 Apr 2026 for MapLight Therapeutics, Inc., €64k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Vishwas Setia: trading record in brief
Vishwas Setia appears in our data through filings on MapLight Therapeutics, Inc. shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 27 October 2025 to 16 April 2026.
Every open-market trade on record is a sale: 3 sales worth €67k. Other entries cover 3 share grants. Since January 2026: no purchases and 3 sales on the market.
On 17 April 2026 came the latest disclosure, an open-market sale for €64k in MapLight Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Vishwas Setia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,806 shares@ US$26.870.0046% mcap96.0% of flowVoting Common StockSEC:0002021256-26-000006:0
- 29 shares@ US$27.010.0000% mcap1.0% of flowVoting Common StockSEC:0002021256-26-000006:1
- 87 shares@ US$27.490.0001% mcap3.1% of flowVoting Common StockSEC:0002021256-26-000006:2
- 43,367 shares0Voting Common StockSEC:0002021256-25-000006:0
4 of 4 declarations